Cannabis Company News

Harvest One Closes $25mm Capital Raise

  Harvest One Announces Closing of $25 Million Financing Related to Acquisition of ACMPR Licensed Medical Cannabis Producer and Swiss Medical Cannabis-Based Health Products Company TORONTO, ONTARIO–(Marketwired – Feb....
- February 22nd, 2017 at 2:39 pm

Tweed to Sell Cannabis Seeds to Home Growers

Introducing the Tweed HomeGrow Collection SMITHS FALLS, ON, Feb. 22, 2017 /CNW/ – Tweed Inc. (Tweed or the Company), a wholly-owned subsidiary of Canopy Growth Corporation (TSX: WEED) (OTC:...
- February 22nd, 2017 at 7:43 am

PharmaCan Capital to Sell 6.7mm Shares at $2.25

PharmaCan Capital Announces $15 Million Bought Deal TORONTO, ONTARIO–(Marketwired – Feb. 14, 2017) – PharmaCan Capital Corp., doing business as Cronos Group (TSXV: MJN) (OTC: PRMCF) (“Cronos” or the...
- February 14th, 2017 at 4:53 pm

Canopy Growth Posts $9.8mm in Sales in Q3

Canopy Growth Corporation Reports Third Quarter Fiscal 2017 Financial Results Increased demand drives double digit quarterly sales growth. Additional growth limited by available strain mix in quarter. Strong product...
- February 14th, 2017 at 7:19 am

Aurora Cannabis Extraction Technology Partnership Advances

Aurora Cannabis and Radient Technologies Provide Update on Exclusive Collaboration Arrangements VANCOUVER, Feb. 13, 2017 /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTC: ACBFF) (Frankfurt:...
- February 13th, 2017 at 7:28 am

Emerald Health Closes Upsized $13.8mm Equity Offering

Emerald Announces Closing of $13.8 Million Bought Deal VICTORIA, Feb. 10, 2017 /CNW/ – Emerald Health Therapeutics Inc. (TSXV: EMH) (“Emerald” or the “Company”) is pleased to announce the closing...
- February 10th, 2017 at 10:41 am

Organigram Implements Enhanced Testing Protocol

Organigram Supports Health Canada Auditing Improvements MONCTON, NEW BRUNSWICK–(Marketwired – Feb 9, 2017) – Organigram Holdings Inc. (TSXV: OGI) (OTC: OGRMF) (the “Company” or “Organigram”) is providing this update...
- February 9th, 2017 at 7:46 am

GW Pharma Reports FY17-Q1 Financials

GW Pharmaceuticals plc Reports First Quarter 2017 Financial Results and Operational Progress Epidiolex® NDA submission and launch preparation on track New Positive Phase 2 glioma data further demonstrates value...
- February 7th, 2017 at 8:44 am

SXSW Interactive to See a Surge of Cannabis Content

The South by Southwest (SXSW) Conference & Festivals, a major gathering in Austin, TX that will celebrate its 31st anniversary this year, is known for allowing attendees to discover the...
- February 5th, 2017 at 6:01 pm

CanniMed Therapeutics Adds 1658 Patients in Q1

CanniMed Therapeutics Inc. Provides Update on Patient Growth Rates, Sales Volume and Product Supply SASKATOON, Saskatchewan–(BUSINESS WIRE)–CanniMed Therapeutics Inc. (TSX:CMED) (“CMED” or the “Company”), a leading plant biopharmaceutical company...
- February 3rd, 2017 at 8:14 am